DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-30 Cr | ₹18 Cr | ₹-165 Cr | ₹159 Cr | ₹210 Cr |
What is the latest Consolidated Net Profit of DISHMAN CARBOGEN AMCIS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-30 Cr |
Mar2023 | ₹18 Cr |
Mar2022 | ₹-165 Cr |
Mar2021 | ₹159 Cr |
Mar2020 | ₹210 Cr |
How is Consolidated Net Profit of DISHMAN CARBOGEN AMCIS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-30 Cr | Negative | |
Mar2023 | ₹18 Cr | Positive | |
Mar2022 | ₹-165 Cr | Negative | |
Mar2021 | ₹159 Cr | -24.64 | |
Mar2020 | ₹210 Cr | - |
Compare Consolidated Net Profit of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹3,984.3 Cr | -4.4% | -9.6% | 52.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | -4.4% |
-9.6% |
52.6% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses